Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.49 |
| ▸ | SHBG | P04278 | 1/20 | 0.46 |
| ▸ | CPN1 | P15169 | 5/20 | 0.41 |
| ▸ | CPB2 | Q96IY4 | 5/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9133567 | 0.98 | CYP2C9 (0.50) | CYP2C9CYP2C19HIF1ASHBGCPN1 | |
| Cyclohexane SCHEMBL4365734 | 0.98 | CYP2C9 (0.50) | CYP2C9CYP2C19HIF1ASHBGCPN1 | |
| SCHEMBL12804034 | 0.98 | CYP2C9 (0.50) | CYP2C9CYP2C19HIF1ASHBGCPN1 | |
| Cyclohexane SCHEMBL16341926 | 0.98 | CYP2C9 (0.50) | CYP2C9CYP2C19HIF1ASHBGCPN1 | |
| Cyclohexane SCHEMBL7426845 | 0.98 | CYP2C9 (0.50) | CYP2C9CYP2C19HIF1ASHBGCPN1 | |
| Cyclohexane SCHEMBL253223 | 0.98 | CYP2C9 (0.50) | CYP2C9CYP2C19HIF1ASHBGCPN1 | |
| Cyclohexane SCHEMBL6631080 | 0.98 | CYP2C9 (0.50) | CYP2C9CYP2C19HIF1ASHBGCPN1 | |
| SCHEMBL13711836 | 0.98 | CYP2C9 (0.50) | CYP2C9CYP2C19HIF1ASHBGCPN1 | |
| SCHEMBL506450 | 0.98 | CYP2C9 (0.50) | CYP2C9CYP2C19HIF1ASHBGCPN1 | |
| SCHEMBL28212852 | 0.98 | CYP2C9 (0.50) | CYP2C9CYP2C19HIF1ASHBGCPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12599138-B2 | Cellulosic fibers comprising internally dispersed cuprous oxide nanoparticles | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2026-04-14 | — | — | US | claimed |
| WO-2023283245-A1 | CELLULOSIC FIBERS COMPRISING INTERNALLY DISPERSED CUPROUS OXIDE NANOPARTICLES | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2023-01-12 | — | — | WO | claimed |
| US-20230011248-A1 | CELLULOSIC FIBERS COMPRISING INTERNALLY DISPERSED CUPROUS OXIDE NANOPARTICLES | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE | 2023-01-12 | — | — | US | claimed |
| CN-115007172-A | Preparation method and application of dimethyl oxalate selective hydrogenation catalyst | 合肥飞木生物科技有限公司 | 2022-09-06 | — | — | CN | claimed |
| CN-114369248-B | Chiral silicon-containing polyester and synthesis method thereof | 中国科学院大连化学物理研究所 | 2022-09-02 | — | — | CN | claimed |
| CN-113354820-B | Chiral polysiloxanes, its synthesis and application | 中国科学院大连化学物理研究所 | 2022-08-19 | — | — | CN | claimed |
| CN-114277398-A | Preparation method and application of nano-copper catalyst | 北京航空航天大学 | 2022-04-05 | — | — | CN | claimed |
| CN-113354820-A | Chiral polysiloxanes, its synthesis and application | 中国科学院大连化学物理研究所 | 2021-09-07 | — | — | CN | claimed |
| EP-3837068-A2 | THIN COPPER FLAKES FOR CONDUCTIVE INKS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (IL) | 2021-06-23 | — | — | EP | claimed |
| CN-111906329-A | Preparation method of copper nano material structure | 中国科学院深圳先进技术研究院 | 2020-11-10 | — | — | CN | claimed |
| US-9060511-B2 | Compositions of dibromomalanomide and their use as biocides | ROHM AND HAAS COMPANY (US) | 2015-06-23 | — | — | US | claimed |
| EP-2582238-B1 | COMPOSITIONS OF DIBROMOMALONAMIDE AND THEIR USE AS BIOCIDES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2014-06-04 | — | — | EP | claimed |
| US-20130142886-A1 | COMPOSITIONS OF DIBROMOMALANOMIDE AND THEIR USE AS BIOCIDES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-06-06 | — | — | US | claimed |
| EP-2582238-A1 | COMPOSITIONS OF DIBROMOMALONAMIDE AND THEIR USE AS BIOCIDES | Dow Global Technologies LLC (US) | 2013-04-24 | — | — | EP | claimed |
| WO-2012021340-A1 | COMPOSITIONS OF DIBROMOMALONAMIDE AND THEIR USE AS BIOCIDES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-02-16 | — | — | WO | claimed |
| EP-0845477-B1 | Reducing agent for reductive alkylation of glycopeptide antibiotics | LILLY CO ELI (US) | 2005-06-01 | — | — | EP | claimed |
| US-5939382-A | PYRIDINE-BORANE AS A REDUCING AGENT | ELI LILLY AND COMPANY (US) | 1999-08-17 | — | — | US | claimed |
| US-5106828-A | METHOD FOR FABRICATING SUPERCONDUCTORS BY SOL-GEL PROCESS | NORTH AMERICAN PHILIPS CORPORATION (US) | 1992-04-21 | — | — | US | claimed |
| US-4963429-A | POLYBUTENE AND POLYETHYLENE WITH ZINC, IRON, ALUMINUM, COBALT, NICKEL, SILVER AND COPPER SALTS DISPERSED THEREIN; DIELECTRICS FOR CAPACITORS | WEA MANUFACTURING INC. (US) | 1990-10-16 | — | — | US | claimed |
| EP-0376536-A2 | Thin oriented polymer films containing metal-organic compounds, and methods of making the same | WEA MANUFACTURING INC. (US) | 1990-07-04 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130142886-A1 | COMPOSITIONS OF DIBROMOMALANOMIDE AND THEIR USE AS BIOCIDES | DDT, BCHE, MGAM | CYP2C9 783/4885CYP2C19 594/4885HIF1A 4722/4885 |
| US-12599138-B2 | Cellulosic fibers comprising internally dispersed cuprous oxide nanoparticles | CROCC, CNBP, SOD1 | CYP2C9 1348/4885CYP2C19 3319/4885HIF1A 1261/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.